|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 78, 351-364, Copyright © 1979 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
AS Geha, H Laks, HC Stansel Jr, JF Cornhill, JW Kilman, MJ Buckley and WC Roberts
Heterograft porcine valves have gained wide acceptance in replacement of
diseased cardiac valves, and their clinical performance in adults has been
very satisfactory over follow-up periods of up to 8 years. Valve
replacement in children is relatively infrequent and experience with
porcine xenografts is necessarily small. Our combined experience at three
university hospitals has been with 25 children, 17 months to 16 years of
age, who have been followed for 10 to 54 months (mean follow-up 33 months).
Porcine valves were used to replace the aortic valve in nine, the mitral
valve in seven, both valves in two, the tricuspid valve in two, and the
pulmonary valve in five patients. Severe bioprosthetic valve dysfunction
has occurred in five (20%) of these patients so far and necessitated
replacement because of severe stenosis in mitral (two) or aortic (three)
valve prostheses at 18 to 45 months after implantation; one postoperative
death occurred among the five reoperations. Pathological examination showed
extensive fragmentation of collagen with focal heavy calcification and
degeneration. In addition we have encountered deterioration and
calcification of two porcine valves in 23 valved conduits followed for 12
to 70 months (mean 43 months), requiring removal and replacement of the
valves 65 and 67 months after implantation. This experience indicates a
disquietingly high incidence of relatively early failure of porcine
xenograft valves in children. This is significantly higher than the failure
rate observed in adult patients. The failure rate is not consistently
related to the small size of an implanted valve which becomes relatively
narrow with the growth of the patient, leading to excessive turbulence and
trauma to the prosthesis. Other factors, including increased turnover of
calcium and accelerated rejection in growing children, may contribute to
these failures and should be examined in order to improve long-term
results. A satisfactory performance would make heterografts the ideal
valvular prosthesis in children, since anticoagulation is avoided.
ARTICLES
Late failure of porcine valve heterografts in children
This article has been cited by other articles:
![]() |
C. Valfre, G. Rizzoli, C. Zussa, P. Ius, E. Polesel, S. Mirone, T. Bottio, and G. Gerosa Clinical results of Hancock II versus Hancock Standard at long-term follow-up. J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 595 - 601.e2. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Monagle, A. Chan, P. Massicotte, E. Chalmers, and A. D. Michelson Antithrombotic Therapy in Children*: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 645S - 687S. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Gudbjartsson, S. Aranki, and L. H. Cohn Mechanical/Bioprosthetic Mitral Valve Replacement Card. Surg. Adult, January 1, 2003; 2(2003): 951 - 986. [Full Text] |
||||
![]() |
A. J. Berrebi, S. M. Carpentier, P. K. Phuong, N. V. Phan, S. M. Chauvaud, and A. Carpentier Results of up to 9 years of high-temperature- fixed valvular bioprostheses in a young population Ann. Thorac. Surg., May 1, 2001; 71 (2007): S353 - S355. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Monagle, A. D. Michelson, E. Bovill, and M. Andrew Antithrombotic Therapy in Children Chest, January 1, 2001; 119(1_suppl): 344S - 370S. [Full Text] [PDF] |
||||
![]() |
D. Mazzitelli, T. Guenther, C. Schreiber, M. Wottke, J. Michel, and H. Meisner Aortic valve replacement in children: are we on the right track? Eur. J. Cardiothorac. Surg., May 1, 1999; 13(5): 565 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Kiziltan, D. A. Theodoro, C. A. Warnes, P. W. O'Leary, B. J. Anderson, and G. K. Danielson Late results of bioprosthetic tricuspid valve replacement in Ebstein's anomaly Ann. Thorac. Surg., November 1, 1998; 66(5): 1539 - 1545. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Zias, C. Mavroudis, C. L. Backer, L. M. Kohr, N. L. Gotteiner, and A. P. Rocchini Surgical repair of the congenitally malformed mitral valve in infants and children Ann. Thorac. Surg., November 1, 1998; 66(5): 1551 - 1559. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Salles, E. Buffolo, J. C. Andrade, J. H. Palma, R. R.P. Silva, R. Santiago, I. S. Casagrande, and M. C. V. Moreira Mitral valve replacement with glutaraldehyde preserved aortic allografts Eur. J. Cardiothorac. Surg., February 1, 1998; 13(2): 135 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Georgiadis, M. Preiss, A. Lindner, Y. Gybels, S. Zierz, and H. R. Zerkowski Doppler Microembolic Signals in Children With Prosthetic Cardiac Valves Stroke, July 1, 1997; 28(7): 1328 - 1329. [Abstract] [Full Text] |
||||
![]() |
D. Mishaly, E. Birk, A. Elami, and B. A. Vidne Autologous Monocusp Pulmonary Valve: Preliminary Results Ann. Thorac. Surg., June 1, 1996; 61(6): 1811 - 1815. [Abstract] [Full Text] |
||||
![]() |
A. S. Kumar, P. N. Rao, and A. Saxena Results of Mitral Valve Reconstruction in Children With Rheumatic Heart Disease Ann. Thorac. Surg., October 1, 1995; 60(4): 1044 - 1047. [Abstract] [Full Text] |
||||
![]() |
M. Ando, Y. Imai, S. Hoshino, and K. Ishihara Autologous Reconstruction of Pulmonary Trunk at Reoperation After Extracardiac Conduit Repair Ann. Thorac. Surg., March 1, 1995; 59(3): 621 - 625. [Abstract] [Full Text] |
||||
![]() |
A. S. Aharon, H. Laks, D. C. Drinkwater, R. Chugh, R. N. Gates, P. W. Grant, L. C. Permut, A. Ardehali, and E. Rudis Early and late results of mitral valve repair in children J. Thorac. Cardiovasc. Surg., May 1, 1994; 107(5): 1262 - 1271. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |